Maternal human parvovirus B19 infection and the risk of fetal death and low birthweight: A case-control study within 35 940 pregnant women

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 116, Issue 11, 2009, Pages 1492-1498

  Sarfraz, A A ^a   Samuelsen, S O ^b,c   Bruu, A L ^d   Jenum, P A ^e   Eskild, A ^a,c  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d VESTFOLD HOSPITAL TRUST   (Norway)

^e VESTRE VIKEN HOSPITAL TRUST   (Norway)

Author keywords

Fetal death; Infection; Parvovirus B19; Pregnancy; Risk factors

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BIRTH CERTIFICATE; BLOOD SAMPLING; CASE CONTROL STUDY; CHILD; CLINICAL ASSESSMENT; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; ERYTHEMA INFECTIOSUM; FEMALE; FETUS; FETUS DEATH; FETUS RISK; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; LIVE BIRTH; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL DISEASE; NORWAY; PARVOVIRUS; POPULATION BASED CASE CONTROL STUDY; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROGENY; PROSPECTIVE STUDY; RISK REDUCTION; SEROCONVERSION; SEROLOGY; STILLBIRTH;

EID: 70049101223     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2009.02211.x     Document Type: Article

References (29)

1. Brodlien K, Tolfvenstam T, Norbeck O. Clinical aspects of parvovirus B19 infection. J Intern Med 2006 260 : 285 304.
2. Silver RM, Varner MW, Reddy U, Goldenberg R, Pinar H, Conway D, et al. Work-up of stillbirth: a review of the evidence. Am J Obstet Gynecol 2007 196 : 433 434.
3. Goldenberg R, Thompson C. The infectious origins of stillbirth. Am J Obstet Gynecol 2003 189 : 861 873.
4. Brown T, Anand A, Ritchie LD, Clewley JP, Reid TM. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet 1984 2 : 1033 1034.
5. Remington JS, Klein JO. Infectious Disease of the Fetus and the Newborn Infant, 3rd edn. Philadelphia, PA : W.B. Sanuders, 1990. pp. 779 801.
6. Anand A, Gray ES, Brown T, Clewley JP, Cohen BJ. Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med 1987 316 : 183 186.
7. Panum Jensen I, Thorsen P, Jeune B, Møller BR, Vestergaard BF. An epidemic of parvovirus B19 in a population of 3596 pregnant women: a study of sociodemographic and medical risk factors. BJOG 2000 107 : 637 643.
8. Van Gessel PH, Gaytant MA, Vossen ACTM, Galama JMD, Ursem NTC, Steegers EAP, et al. Incidence of parvovirus B19 infection among an unselected population of pregnant women in the Netherlands: a prospective study. Eur J Obstet Gynecol Reprod Biol 2006 128 : 46 49.
9. Yaegashi N, Niinuma T, Chisaka H, Uehara S, Okamura K, Shinkawa O, et al. Serologic study of human parvovirus B19 infection in pregnancy in Japan. J Infect 1999 38 : 30 35.
10. De Freitas RB, Wong D, Boswell F, De Miranda MFR, Linhares AC, Shirley J, et al. Prevalence of human parvovirus (B19) and Rubellavirus infections in urban and remote rural areas in northern Brazil. J Med Virol 1990 32 : 203 208.
11. Harger JH, Adler SP, Koch WC, Harger GF. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms. Obstet Gynecol 1998 91 : 413 420.
12. Hall SM. Prospective study of human parvovirus (B19) infection in pregnancy. Br Med J 1990 300 : 1166 1170.
13. Miller E, Fairley CK, Cohen BJ, Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. BJOG 1998 105 : 174 178.
14. Chisaka H, Ito K, Niikura H, Sugawara J, Takano T, Murakami T, et al. Clinical manifestations and outcome of parvovirus B19 infection during pregnancy in Japan. Tohoku J Exp Med 2006 209 : 277 283.
15. Enders M, Weidner A, Zoellner I, Searle K, Enders G. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 2004 24 : 513 518.
16. Yaegashi N, Niinuma T, Chisaka H, Watanabe T, Uehara S, Okamura K, et al. The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection; report of 10 cases and meta-analysis. J Infect 1998 37 : 28 35.
17. Kerr JR, O'Neill HJ, Coyle PV, Thompson W. An outbreak of parvovirus B19 infection; a study of clinical manifestations and the incidence of fetal loss. Ir J Med Sci 1994 163 : 65 67.
18. Kinney JS, Anderson LJ, Farrar J, Strikas RA, Kumar ML, Kliegman RM, et al. Risk of adverse outcomes of pregnancy after human parvovirus B19 infection. J Infect Dis 1988 157 : 663 667.
19. Tolfvenstam T, Papadogiannakis N, Norbeck K, Broliden K. Frequency of human parvovirus B19 infection in inrauterine fetal death. Lancet 2001 357 : 1494 1497.
20. Jenum PA, Stray-Pedersen B, Melby KK, Kapperud G, Whitelaw A, Eskild A, et al. Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol 1998 36 : 2900 2906.
21. Statistics in Norway. Statistical Yearbook 1993, Issue 12. Oslo, Norway : Statistics Norway, 1993.
22. Rasmussen S, Albrechtesen S, Irgens LM, Dalaker K, Maratmann-Moe H, Valtkovic L, et al. Unexplained antepartum fetal death in Norway 1985-97: diagnostic validation and some epidemiologic aspects. Acta Obstet Gynecol Scand 2003 82 : 109 115.
23. Rasmussen S, Albrechtesen S, Irgens LM, Dalaker K, Maartmann-Moe H, Valtkovic L, et al. Risk factors for unexplained antepartum fetal death in Norway 1967-98. Early Hum Dev 2003 71 : 39 52.
24. Eskild A, Jeansson S, Stray-Pedersen B, Jenum PA. Herpes simplex virus type -2 infection in pregnancy: no risk of fetal death: results from a nested case control study within 35,940 women. BJOG 2002 109 : 1030 1035.
25. Koch WC, Harger JH, Barnstein BBS, Adler SP. Serologic and virologic evidence for frequent intrauterine transmission of human parvovirus B19 with a primary maternal infection during pregnancy. Pediatr Infect Dis J 1998 17 : 489 494.
26. Bruu AL, Nordbø SA. Evaluation of five commercial tests for detection of immunoglobulin M antibodies to human parvovirus B19. J Clin Microbiol 1995 33 : 1363 1365.
27. Roger BB. Parvovirus B19: twenty-five years in perspective. Pediatr Dev Pathol 1999 2 : 296 315.
28. Gibbs RS. Subclinical infection as a cause of preterm delivery. Pediatr Infect Dis J 1990 9 : 777 778.
29. Norwegian Institute of Public Health. New outbreak of erythema infectiosum. MSIS report 8 (March 1st), 1994.